Sit Investment Associates »

Arcutis Biotherapeutics shares owned by Sit Investment Associates

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Sit Investment Associates from 13F filings

Historical chart of Sit Investment Associates investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Sit Investment Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Sit Investment Associates

Quarter filed Position value Share count Share price at filing
2026-06-30 $758k 29k 26.23
2026-03-31 $681k 29k 23.56
2025-12-31 $376k 13k 29.03

More positions owned by Sit Investment Associates

Nvidia Corp Common (NVDA)
Broadcom Common (AVGO)
Angel Oak Financial Strat Common (FINS)
Apple Common (AAPL)
Blackrock Taxable Muni Bond Tr Common (BBN)
Blackrock Core Bond Trust Bhk Common (BHK)
Microsoft Corp Common (MSFT)
Alphabet Inc - Cl A Common (GOOGL)
Putnam Premier Income Trust Pp Common (PPT)
Tcw Strategic Income Fd Tsi Common (TSI)
Dws Municipal Income Trust Ktf Common (KTF)
Applied Materials Common (AMAT)
Aberdeen Intermediate Inc Fd M Common (MIN)
Eaton Vance Limited Duration I Common (EVV)
Putnam Master Intermediate Common (PIM)

View all positions for Sit Investment Associates

Top funds holding Arcutis Biotherapeutics

Suvretta Capital Management
BlackRock
Frazier Life Sciences Management
Rubric Capital Management
Polar Capital Holdings
State Street Corporation
Vanguard Capital Management
Jennison Associates
Morgan Stanley
D. E. Shaw & Co
UBS Group
Bank of America Corporation
Geode Capital Management
Vanguard Portfolio Management
OrbiMed Advisors

View all funds holding Arcutis Biotherapeutics